Anne Marijn Kramer, MD, PhD^1,2,3, Hrishikesh Srinagesh, MD, MSCR^4*, Yi-Jiun Su, MD^4,5*, Mark P. Hamilton, MD, PhD^6,7, Kendall Levine^8*, Eleonora Migliore^8*, Kimi DeNoble^8*, Annie K. Brown, MS^9*, Kristen Cunanan, PhD^10*, Neha Agarwal, MS^2,4*, Claire Lohman^11*, Sharon Mavroukakis, MS^12*, Sushma Bharadwaj, MD¹³, Sally Arai, MD¹⁴, Laura Johnston, MD¹⁴, Robert Lowsky, MD^14*, Everett H. Meyer, MD, PhD¹⁵, Robert S. Negrin, MD¹⁴, Andrew R. Rezvani^14*, Judith Shizuru^14*, Lekha Mikkilineni, MD, MA¹⁶, Hitomi Hosoya, MD, PhD¹⁷, Parveen Shiraz^14*, Surbhi Sidana, MD¹⁸, Wen-Kai Weng, MD, PhD⁴, Vanessa E. Kennedy, MD¹⁶, Melody Smith, MD, MS¹⁸, Saurabh Dahiya, MD, FACP^14*, Kara L. Davis, DO^19*, Sneha Ramakrishna, MD^20*, Liora Michal Schultz, MD²⁰, Ramya Tunuguntla, PhD^21*, Steven A. Feldman, PhD^2*, Lori Muffly, MD¹⁸, Crystal L. Mackall, MD¹², David B. Miklos, MD, PhD^6,16 and Matthew J. Frank^14,22

¹Cancer Center Amsterdam, Department of Hematology, Amsterdam UMC, Amsterdam, Netherlands
²Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA
³Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Menlo Park, CA
⁴Division of Blood and Marrow Transplantation & Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
⁵Division of Hematology-Oncology, Chang Gung Memorial Hospital at Linkou, Taoyuan City, Taiwan
⁶Stanford Cancer Institute, Center for Cancer Cell Therapy, Stanford University, Stanford, CA
⁷Department of Medicine, Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
⁸Department of Bone Marrow Transplant and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
⁹Laboratory of Cell and Gene Medicine, Stanford University School of Medicine, Palo Alto, CA
¹⁰Quantitative Sciences Unit, Stanford University School of Medicine, Palo Alto, CA
¹¹Cancer Correlative Science Unit, Stanford Cancer Institute, Palo Alto, CA
¹²Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA
¹³Division of Blood and Marrow Transplantation and Cellular Therapy, Department of Medicine, Stanford University School of Medicine, Stanford, CA
¹⁴Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA
¹⁵Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University Medical Center, Stanford, CA
¹⁶Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
¹⁷Division of Bone Marrow Transplant & Cellular Therapy,, Stanford University, Palo Alto, CA
¹⁸Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA
¹⁹Stanford University, Stanford, CA
²⁰Department of Pediatrics, Division of Hematology and Oncology, Stanford University School of Medicine, Palo Alto, CA
²¹Center for Cancer Cell Therapy, Stanford University, Stanford, CA
²²Stanford Cancer Institute, Center for Cancer Cell Therapy, Stanford University School of Medicine, Stanford, CA

Elad Jacoby, MD¹, Reut Fluss, PhD^1*, Efrat Glick Saar, PhD^1*, Shachar Naor, MD^1*, Ortal Barel, PhD^1*, Niv Sabath^2*, Noa Sher, PhD^2*, Noa Greenberg-Kushnir, MD^1*, Bella Bielorai, MD^3*, Natalie Yivgi Ohana, PhD^2*, Amos Toren^4* and Gideon Rechavi, MD, PhD^1*

¹Sheba Medical Center, Ramat Gan, Israel
²Minovia Therapeutics, Tirat Carmel, Israel
³Sheba Medical Center, Ramat-Gan, Israel
⁴Sheba Medical Center, Tel-Hashomer, Israel

Michael H. Kramer, MD, PhD¹, Neha Mehta-Shah, MD², Michael P. Rettig, PhD³, Katherine Stricker^3*, Melinda Harding^3*, Feng Gao^4*, Brett Ramsey, MBA^5*, Peter Westervelt, MD³, Jan K Davidson-Moncada, MD, PhD, MSc⁵, Armin Ghobadi, MD², John F. DiPersio, MD, PhD³ and Geoffrey L. Uy, MD⁶

¹Division of Oncology, Department of Medicine, Washington University School of Medicine, Saint Louis, MO
²Division of Oncology, Washington University School of Medicine, St. Louis, MO
³Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁴Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, Saint Louis, MO
⁵Wugen, Saint Louis, MO
⁶Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO

Robert Weinkove, MBBS PhD^1,2*, Philip George, MBBS^1,2*, Robert Fyfe, MBChB^1,2*, Aine Hurley, MBBChir^1,2*, Nathaniel Dasyam, PhD^1*, Yasmin Nouri, PhD^1,3*, Tess Ostapowicz^1,4*, Stefan Mullins, MB BCh^1,2*, Giulia Giunti, PhD^5*, Brittany Lavender^1*, Brigitta Mester, PhD^1*, Catherine M. Bollard, MD⁶, Travis Perera, MBChB^2*, Hayden Jina, MBChB^2*, Alwyn D'Souza, MBChB^2*, Le Qin, PhD^7*, David S. Ritchie, MBChB PhD⁸, Chris M.A. Frampton, PhD^9*, Rachel Perret, PhD^1*, Peng Li, PhD^7,10* and Ian Hermans, PhD^1*

¹Cancer Immunotherapy Programme, Malaghan Institute of Medical Research, Wellington, New Zealand
²Te Rerenga Ora Wellington Blood & Cancer Centre, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand
³Division of Immunology, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
⁴Clinical Trials Unit, Te Whatu Ora Health New Zealand Capital Coast & Hutt Valley, Wellington, New Zealand
⁵BioOra, Wellington, New Zealand
⁶Children's National Health System and The George Washington University, Washington, DC
⁷Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou, China
⁸Department of Medicine, The University of Melbourne, Melbourne, VIC, Australia
⁹Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand
¹⁰Wellington Zhaotai Therapies Limited, Wellington, New Zealand

Sairah Ahmed, MD¹, John F. DiPersio, MD, PhD², James H Essell, MD³, Catherine S. Diefenbach⁴, Miguel Angel Perales, MD⁵, Cristina Castilla-Llorente, MD^6*, Saurabh Dahiya, MD⁷, Sohail Chaudhry, MD, PhD^8*, Heng Xu, PhD^8*, Yi Liu, PhD^8*, Christie Fanton, PhD^8*, Zachary Lee, PharmD^8*, Mario Q. Marcondes, MD, PhD⁹, Mary Tagliaferri, MD^8*, Jonathan Zalevsky, PhD^8*, David B. Miklos, MD, PhD⁷, Cameron J. Turtle, MBBS, PhD^10,11* and Joseph P. McGuirk, DO¹²

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Division of Oncology, Washington University School of Medicine, Saint Louis, MO
³Oncology/Hematology Care, Cincinnati, OH
⁴Perlmutter Cancer Center, NYU Langone Health, New York, NY
⁵Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Gustave Roussy Cancer Campus, Villejuif, France
⁷Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Palo Alto, CA
⁸Nektar Therapeutics, San Francisco, CA
⁹Nektar Therapeutics, Millbrae, CA
¹⁰Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
¹¹University of Sydney, Sydney, NSW, Australia
¹²Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS

Susan Bal, MD^1*, Myo Htut, MD², Jesús G. Berdeja, MD³, Larry D Anderson Jr., MD, PhD⁴, Adriana Rossi, MD, MSc⁵, Tara Gregory, MD⁶, Thomas G. Martin, MD⁷, Luciano J. Costa, MD, PhD⁸, Hongxiang Hu, PhD^9*, Jinjie Chen, PhD^9*, Chaoqun Mei, PhD^9*, Naomey Sarkis, PharmD, RPh^9*, Alok Shrestha, MSc^9*, Safiyyah Ziyad, PhD^9*, Wei-Ming Kao, MD, PhD^9*, Allison J Kaeding, MD^9*, Michael R. Burgess, MD, PhD⁹ and Omar Nadeem, MD¹⁰

¹University of Alabama at Birmingham, Birmingham, AL
²City of Hope Comprehensive Cancer Center, Duarte, CA
³Sarah Cannon Cancer Center at Tennessee Oncology, Nashville, TN
⁴Hematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, UT Southwestern Medical Center, Dallas, TX
⁵Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY
⁶Sarah Cannon Cancer Network, Colorado Blood Cancer Institute, Denver, CO
⁷University of California, San Francisco, San Francisco, CA
⁸Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Vestavia, AL
⁹Bristol Myers Squibb, Princeton, NJ
¹⁰Dana-Farber Cancer Institute, Boston, MA

Mark Blaine Geyer, MD^1,2, Susan DeWolf, MD^3*, Xiaoli Mi, MD¹, Brian C. Shaffer, MD, MS⁴, Briana Cadzin, RN^5*, Devin McAvoy^6*, Kinga K. Hosszu, PhD^6*, Kenyon Weis^7*, Rachel Lorenc^8*, Alexander M. Lewis^7*, Narina N. Girotra^7*, Erin R. Burns^9*, Jasmine S. Um^9*, Sarah Yoo^9*, Zoe Katsamakis^6*, Xiuyan Wang, PhD^10*, Isabelle Riviere^11*, Kevin J. Curran, MD^12*, Jae H. Park, MD^3,13, Marcel R.M. van den Brink, MD, PhD¹⁴, Omar Abdel-Wahab, MD^2,7,8, Renier Brentjens, MD PhD¹⁵ and Anthony F. Daniyan, MD^1,3*

¹Department of Medicine, Cell Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY
²Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medicine, Leukemia Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁴Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
⁵Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, NY
⁶Department of Pediatrics, Immune Discovery and Modeling Service, Memorial Sloan Kettering Cancer Center, New York, NY
⁷Molecular Pharmacology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY
⁸Weill Cornell Medical College, New York, NY
⁹Memorial Sloan Kettering Cancer Center, New York, NY
¹⁰Michael G. Harris Cell Therapy and Cell Engineering Facility, Memorial Sloan Kettering Cancer Center, New York, NY
¹¹Takeda Development Center Americas, Inc., Lexington, MA
¹²Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY
¹³Cell Therapy Service and Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
¹⁴Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA
¹⁵Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Hany Elmariah, MD, MS¹, Jongphil Kim, PhD^2*, Kayla Reid, MS^3*, Christopher Cubitt, PhD^4*, Andrew T. Kuykendall, MD⁵, Jeffrey E Lancet, MD⁵, Rami S. Komrokji, MD⁵, David Sallman, MD⁵, Eric Padron, MD⁵, Onyee Chan, MD⁵, Kendra L. Sweet, MD⁵, Alison R. Walker, MD, MBA, MPH⁵, Albert J Ribickas^4*, Stephanie Dormesy^6*, Debra A Kessler^6*, Priscilla M Abedu^6*, Asmita Mishra, MD, MBA¹, Farhad Khimani, MD^1*, Lia Perez, MD^1*, Joseph A. Pidala, MD, PhD¹, Claudio Anasetti, MD^1*, Ephraim Joseph Fuchs, MD, MBA⁷, Philip Imus, MD⁷, Michael D. Jain, MD, PhD¹, Frederick L. Locke, MD¹, Marco Davila, MD, PhD⁸, Nelli Bejanyan, MD¹ and Amy E. DeZern, MD, MHS⁷

¹Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
²Department of Biostatistics and Bioinformatics, Moffitt Cancer Center, Tampa, FL
³Department of Clinical Science, Moffitt Cancer Center, Tampa, FL
⁴Moffitt Cancer Center, Tampa, FL
⁵Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
⁶New York Blood Center, New York, NY
⁷Johns Hopkins University, Baltimore, MD
⁸Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY

Juan Du, MD, PhD¹, Wanting Qiang^1*, Jing Lu, MD^1*, Yanchun Jia^1*, Haiyan He^1*, Jin Liu^1*, Pei Guo^1*, Ying Yang^1*, Zhongyuan Feng^1*, Lina Jin^1*, Xiaoqiang Fan^1*, Nina Shah, MD², Qi Zhang^3*, Jia Liu^4*, Lihong Weng^3*, Lianjun Shen^3* and Wei Cao^3*

¹Department of Hematology, Myeloma & Lymphoma Center, Shanghai Changzheng Hospital, Shanghai, China
²AstraZeneca, South San Francisco, CA
³Gracell Biotechnologies Ltd., Shanghai, China
⁴Gracell Biotechnologies Ltd., Shanghai, FL, China

Johanna Richter^1*, Felix Fischbach, M.D.^2*, Lena Kristina Pfeffer, M.D.^2*, Boris Fehse, PhD^1*, Susanna Carolina Berger, M.D.^1*, Stefanie Reinhardt^2*, Mathias Schäfersküpper^1*, Franziska Elisabeth Marquard, M.D.^1*, Kristin Rathje^3*, Nico Gagelmann, M.D.^1*, Anita Badbaran, M. Sc.^1*, Catherina Lück, M.D.^1*, Dietlinde Janson, M.D.^1*, Christine Wolschke, M.D.^1*, Dominic Borie, M.D., Ph.D.^4*, Johann Seibel^5*, Francis A. Ayuk, M.D.^1*, Manuel Friese, M.D.^2*, Christoph Heesen, MD^2* and Nicolaus Kroeger, M.D.¹

¹Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
²Institute of Neuroimmunology and Multiple Sclerosis and Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
³Department of Stem Cell Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, AL, Germany
⁴Kyverna Therapeutics, Emeryville, CA
⁵Institute for Transfusion Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

Yongxian Hu^1,2,3,4*, Mingming Zhang^1,2,5,6*, Shan Fu^2,5,7*, Ruimin Hong^2,5,8*, Jiazhen Cui^1,2,5,9*, Simao Huang^9*, Min Gao, PhD^10*, Daojun Bai^10*, Jingjing Ren, PhD, MD^10*, Xingbing Wang^11*, Yugang Guo, PhD^10,12*, Li Tang, PhD^13* and He Huang, MD^2,4,14,15*

¹Liangzhu Laboratory, Zhejiang University Medical Center, Hangzhou, China
²Institute of Hematology, Zhejiang University, Hangzhou, China
³Zhejiang Province Engineering Laboratory for Stem Cell and Immunity Therapy, Hangzhou, China
⁴Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁵Zhejiang Province Engineering Research Center for Stem Cell and Immunity Therapy, Hangzhou, China
⁶Bone Marrow Transplantation Center of The First Affiliated Hospital Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
⁷Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁸Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
⁹Bone Marrow Transplantation Center of The First Affiliated Hospital Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
¹⁰Leman Biotech Co., Ltd., Shenzhen, China
¹¹The Flirst Affiliated Hospital Of University of Science and Technology of China, Hefei, Anhui, CHN
¹²Institute of Drug Metabolism and Pharmaceutical Analysis, College of Pharmaceutical Sciences, Zhejiang University; State Key Laboratory of Advanced Drug Delivery and Release Systems, Zhejiang University, Hangzhou, China
¹³Institute of Materials Science & Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
¹⁴Liangzhu Laboratory, Zhejiang University Medical Center, HangZhou, China
¹⁵Zhejiang Laboratory for Systems & Precision Medicine, Zhejiang University, Hangzhou, China

Junfang Yang^1,2*, Xian Zhang, MD^1,2*, Jingjing Li^1,2*, Liyuan Qiu^2*, Lin Wang^3* and Peihua Lu, MD^1,2

¹Beijing Lu Daopei Institute of Hematology, Beijing, China
²Hebei Yanda Lu Daopei Hospital, Langfang, China
³Hebei Senlang Biotechnology, Shijiazhuang, China

Swati Naik, MBBS¹, Madden Renee, MD^2*, Aimee C. Talleur, MD², Rebecca Epperly, MD², Timothy Lockey, PhD^3*, Jennyfer Bran, MD^4*, Liqing Tian^5*, Ying Li^6*, Dinesh Keerthi^2*, Alexandra Boyd^7*, Amanda Lipsitt^4*, Jeffrey E. Rubnitz, MD, PhD⁸, Jeffery M Klco, MD, PhD⁹, Barry Shulkin, MD^10*, Sarah Schell^5*, Polly Adams^7*, Jeoungeun John Park^4*, Janice Riberdy, PhD^11*, Na Shang^4*, Jaquelyn T. Zoine, PhD⁵, Raghuvaran Shanmugam^12*, Chris Nevitt, PhD^2*, Unmesha Thanekar^7*, Jennifer Wallace^4*, Elaine Harstead^4*, Scott Perry^7*, Catherine Willis^5*, Jean-Yves Metais, Ph.D.^2*, Deanna M. Langfitt, PhD^13*, Sheng Zhou, PhD¹⁴, Salem M. Akel, PhD^15*, Caitlin Zebley, MD, PhD^6*, Jeremy Chase Crawford, PhD^12*, Benjamin Youngblood, PhD^16*, Paul G. Thomas, PhD^12*, Frank Fazio^5*, Brandon M Triplett, MD^2*, Stephen Gottschalk, MD² and Mireya Paulina Velasquez, MD²

¹Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TX
²Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
³Department of Therapeutics Production and Quality, St. Jude Children's Research Hospital, Memphis, TN
⁴ST. JUDE CHILDREN'S RESEARCH HOSPITAL, Memphis, TX
⁵St. Jude Children's Research Hospital, Memphis, TN
⁶Department of Bone Marrow Transplantation and Cellular Therapy, St Jude Children's Research Hospital, Memphis, TN
⁷St Jude Children's Research Hospital, Memphis, TN
⁸Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN
⁹Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
¹⁰Department of Diagnostic Imaging, St. Jude Children's Research Hospital, University of Tennessee Health Science Center, Memphis, TN
¹¹Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
¹²Department of Host Microbe Interactions, St. Jude Children's Research Hospital, Memphis, TN
¹³Department of Bone Marrow Transplant and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN
¹⁴Experimental Cellular Therapeutics Laboratory, St. Jude Children's Research Hospital, Memphis, TN
¹⁵St. Jude Children’s Research Hospital, Memphis, TN
¹⁶St Jude Children's Research Hospital, Memphis

Edward R Scheffer Cliff, MBBS, MPH¹, Penelope Lafeuille^2*, Sheila Diamond, MS, CGC^2*, Jacob Aptekar, MD, PhD^2*, David A Russler-Germain, MD, PhD³, Kai Rejeski, MD⁴ and Aaron S Kesselheim, MD, JD, MPH^5*

¹Peter MacCallum Cancer Centre, Parkville, Australia
²Medidata AI, Medidata, a Dassault Systemes Company, New York, NY
³Siteman Cancer Center, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁴Department of Medicine III, LMU University Hospital, Munich, Germany
⁵Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA

Sumithira Vasu, MD, MBBS¹, Evandro Bezerra, MD², Nathan Denlinger, DO, MS², Nicole Szuminski^1*, Dina Schneider, PhD³, Pradyot Dash, PhD⁴, Louisa Wirthlin^5*, Narendranath Epperla, MD, MS⁶, Yazeed Sawalha, MD², Jennifer A. Woyach, MD⁷, Kerry A. Rogers, MD², Seema A Bhat, MD², Gregory K Behbehani, MD, PhD⁸, Karilyn T. Larkin, MD⁸, Adam S Kittai, MD⁹, Wing Chan, PhD¹⁰, Ashley Angell Krull^11*, Shamama Nishat, PhD^1*, Lynn O'Donnell, PhD^1*, Lapo Alinari, MD, Ph.D¹⁰ and Marcos de Lima, MD¹²

¹The Ohio State University, Columbus, OH
²Division of Hematology, The Ohio State University, Columbus, OH
³Lentigen, Gaithersburg, MD
⁴Lentigen, a Miltenyi Biotec Company, Gaithersburg, MD
⁵Miltenyi Biotec, Gaithersburg, MD
⁶Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Columbus, OH
⁷Division of Hematology, Ohio State University Comprehensive Cancer Center, Columbus, OH
⁸Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
⁹Icahn School of Medicine at Mount Sinai, New York, NY
¹⁰James Comprehensive Cancer Center, The Ohio State University, Columbus, OH
¹¹The Ohio State University Wexner Medical Center, Columbus, OH
¹²Department of Internal Medicine, Division of Hematology, The Ohio State University - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Columbus, OH

Nicolas Gazeau^1*, David Beauvais, MD^2*, Rémi Tilmont^1*, Micha Srour^3*, Emmanuelle Ferrant^4,5,6*, Violaine Safar, MD^7*, Gandhi Damaj, MD, PhD^8,9*, Nicolas Gower^10*, Nicolas Duployez, PharmD, PhD^11*, Sarah Huet^12*, Herve Ghesquieres, MD, PhD^13*, Emmanuel Bachy, MD, PhD¹⁴, Franck Morschhauser, MD, PhD¹, Ibrahim Yakoub-Agha, MD, PhD^15*, Mael Heiblig^16* and Pierre Sesques, MD^17*

¹Centre Hospitalier Universitaire de Lille, Lille, France
²Hematology Department., CHRU Lille, Lille, FRA
³CHU de Lille, Lille, France
⁴Department of Hematology, Lyon Sud Hospital, Pierre Benite, France
⁵Hospices Civils de Lyon, Centre Hospitalier Lyon Sud, Service d’Hématologie Clinique, Pierre-Bénite, France
⁶CHU Lyon Sud, Pierre Benite, FRA
⁷Department of hematology, Lyon Sud university hospital, HCL, Lyon, France
⁸CHU Caen, Caen, Normandy, FRA
⁹Hematology Institute, University Of Caen Normandie Hospital Center, Caen, France
¹⁰Clinical Hematology, Lille University Hospital, Lille, France
¹¹Laboratory of Hematology-Molecular Biology, Centre Hospitalier Universitaire (CHU) de Lille, Lille, France
¹²Laboratory of Haematology, CHU Lyon-Sud, Hospices Civils de Lyon, Pierre-Benite, Lyon, France
¹³Hematology Department, Centre Hospitalier Lyon Sud, Pierre-Bénite, France
¹⁴Lyon Sud Hospital, Lyon, France
¹⁵CHU de Lille, Univ Lille, INSERM U1286, Infinite, 59000, LILLE, France
¹⁶Hematology Department, Hospices Civils de Lyon, Pierre Bénite, Lyon, France, LYON, FRA
¹⁷CHU Lyon-Sud, Hospices Civils de Lyon, Lyon, France

Milos D Miljkovic, MD, MSc¹, Adam S. Asch, MD^2*, Gregory Orloff, MD^3*, Ralph Boccia, MD^4*, Jesús G Berdeja, MD⁵, Fevzi Altuntas, MD^6*, Stefan O. Ciurea, MD⁷, James F Howard Jr., MD^8*, Tuan Vu, MD^9*, Bennett Myers, MD^10*, Nizar Chahin, MD^11*, Tahseen Mozaffar, MD^12*, Christopher M Jewell, PhD^13* and Metin Kurtoglu, MD, PhD^13*

¹Cartesian Therapeutics, Frederick, MD
²Oklahoma University/Stephenson Cancer Center, Oklahoma City, OK
³Virginia Cancer Specialists, Fairfax, VA
⁴Center for Cancer and Blood Disorders, Johns Hopkins Medicine, Bethesda, MD
⁵Sarah Cannon Center For Blood Cancers, Nashville, TN
⁶Ankara Oncology Training and Research Hospital, Yenimahalle/Ankara, Ankara, Turkey
⁷Hematopoietic Stem Cell Transplantation and Cellular Therapy Program, Division of Hematology/Oncology, Department of Medicine, University of California Irvine, Orange, CA
⁸Department of Neurology, University of North Carolina Chapel Hill, Chapel Hill, NC
⁹Department of Neurology, University of South Florida, Tampa, FL
¹⁰DENT Neurologic Institute, Buffalo, NY
¹¹Department of Neurology, Oregon Health and Sciences University, Portland, OR
¹²Department of Neurology, University of California Irvine, Irvine, CA
¹³Cartesian Therapeutics, Gaithersburg, MD

Hidetaka Nakagaki, MD^1*, Takuji Yamauchi, MD, PhD^2*, Takahiko Mukaino^3*, Ayumi Sakata^4*, Eriko Watanabe^5*, Mitsuru Watanabe^3*, Daisuke Ishihara^6*, Hiroshi Imanaga, MD^7*, Kensuke Sasaki, MD, PhD^7*, Teppei Sakoda^6*, Fumiaki Jinnouchi^8*, Kohta Miyawaki^8*, Takahiro Shima, MD, PhD⁹, Yoshikane Kikushige^10*, Yasuo Mori, M.D., Ph.D.^11*, Yuya Kunisaki^6*, Taeko Hotta^12*, Hiroshi Shigeto^13*, Noriko Isobe^3*, Koichi Akashi, MD, PhD^2* and Koji Kato, MD, PhD⁷

¹Department of Hematology, Oncology & Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan
²Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
³Department of Neurology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, JPN
⁴Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Hosp, Fukuoka, JPN
⁵Department of Clinical Chemistry and Laboratory Medicine, Kyushu University Hosp, Fukuoka, Japan
⁶Kyushu University Graduate School of Medical Sciences, Fukuoka, JPN
⁷Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
⁸Kyushu University, Fukuoka, JPN
⁹Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medicine, Fukuoka, Japan
¹⁰Center for Cellular and Molecular Medicine, Fukuoka, JPN
¹¹Hematology, Oncology & Cardiovascular medicine, Kyushu University Hospital, Fukuoka, JPN
¹²Kyushu University Hospital, Fukuoka, JPN
¹³Division of Medical Technology, Department of Health Sciences, Graduate School O, Fukuoka, JPN

Yifan Zhao^1*, Xue Bai^1*, Shujing Guo^1*, Xiaomei Zhang^2* and Mingfeng Zhao^2,3

¹Tianjin First Central Hospital, Tianjin, China
²Medical School of Nankai University, Tianjin, China
³Department of Hematology, Tianjin First Central Hospital, School of Medicine, Nankai University, Tianjin, China

Anupama Deepa Kumar, MD¹, Ajai Chari, MD¹, Srishti Gupta^2*, Joseph Rohr, MD, PhD^3*, Rajesh Belani, MD^4*, Blair Madison, PhD^4*, Zhibo Ma, PhD^4*, Chris E Martin, PhD^4*, Katherine McArthur^5*, Hilary Ostwald^6*, Syed Rizvi, MD⁷ and Thomas G. Martin, MD⁸

¹University of California, San Francisco, San Francisco, CA
²University of California San Francisco, San Francisco, CA
³UCSF, San Francisco, CA
⁴Poseida Therapeutics, San Diego, CA
⁵Poseida Therapeutics, San Deigo, CA
⁶Poseida Therapeutics, Inc., San Diego, CA
⁷Poseida Therapeutics, Inc., San Diego
⁸Department of Hematology, University of California at San Francisco, San Francisco, CA

Maria Isabel Arbelaez Monroy, MD^1*, Nil Albiol, MD^2*, Alexandra Martínez-Roca^2,3*, Nuria Martínez-Cibrián, MD^4*, Cristina Arnaldos^5*, Marta Español-Rego^6*, Sergio Navarro-Velazquez^7*, Helena Brillembourg^1*, Beatriz Merchan^1*, Leticia Alserawan^8*, Maria Castella^7*, Daniel Benitez-Ribas^9*, Mercedes Montoro-Lorite^10*, Pilar Ayora^2*, Carla Ramos^4*, Carlos Fernández de Larrea, MD¹¹, E. Azucena González-Navarro^1*, Alvaro Urbano-Ispizua, MD, PhD¹, Jordi Esteve Reyner¹, Manel Juan^12*, Julio Delgado, MD, PhD^1*, Luis Gerardo Rodríguez-Lobato^13* and Valentin Ortiz-Maldonado, MD, PhD, MSc¹⁴

¹Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, Spain
²Hematology Department, Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, Spain
³Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), Barcelona, Spain
⁴Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, Spain
⁵Immunology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, Barcelona, Spain
⁶Immunology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, Spain
⁷Immunology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Barcleona, Spain
⁸Hospital Clínic de Barcelona, Barcelona, Spain
⁹Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, ESP
¹⁰Hematology Department, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, ESP
¹¹Hosp. Clinic I Provincial de Barcelona, Barcelona, Spain
¹²Immunology Department, Hospital Clínic de Barcelona, Barcelona, Spain, Plataform of Immunotherapy Clínic-Sant Joan de Déu, Barcelona; Spain, Barcelona, ESP
¹³Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain., Barcelona, Spain
¹⁴Hematology Department, Hematology Department, Hospital Clínic Barcelona, Barcelona, Spain, Barcelona, ESP

Naseem S. Esteghamat, MD^1,2, Joseph M Tuscano, MD¹, Brian A. Jonas, MD, PhD³, Aaron S. Rosenberg, MD⁴, Rasmus T. Hoeg, MD^5*, Francisco Andres Socola, MD¹, Brian Fury^6*, Jordan Pavlic, MA^7*, Geralyn Annett^8*, Jan A. Nolta, PhD^9* and Mehrdad Abedi, MD^10*

¹Department of Internal Medicine, Division of Malignant Hematology/Cellular Therapy and Transplantation, University of California, Davis Medical Center Comprehensive Cancer Center, Sacramento, CA
²UC Davis Comprehensive Cancer Center, Sacramento
³UC Davis Comprehensive Cancer Center, Davis, CA
⁴UC Davis Comprehensive Cancer Center, Sacramento, CA
⁵Comprehensive Cancer Center, University of California, Davis, Sacramento, CA
⁶UC Davis GMP Facility, Sacramento
⁷University of California, Davis Graduate Group in Immunology, GMP Facility, Sacramento, CA
⁸Department of Internal Medicine, University of California, Davis, Sacramento, CA
⁹University of California, Davis, Sacramento, CA
¹⁰University of California Davis, Sacramento, CA

Gil Fridberg, MD^1,2,3,4*, Odelia Amit, MD^3*, Mohamad Ganayem, MD^5*, Felix Bukstein, MD^6,7*, Chava Perry, MD^3,7*, Irit Avivi Mazza^3,7,8,9,10*, Ronit Gold, RN^11* and Ron Ram, MD^7,12,13,14

¹Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel, Tel Aviv, Israel
²Hematology Division, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
³BMT Unit, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁴Department of Hematology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁵BMT Unit Tel Aviv Sourasky Medical Center, Tel Aviv, ISR
⁶Neuro Oncology Unit Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
⁷Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
⁸Tel Aviv Sourasky Medical Center and Tel Aviv University, Tel Aviv, Israel
⁹Tel Aviv Sourasky Medical Center, Tel Aviv, Israel
¹⁰Hematology Division, Sourasky Medical Center and the Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
¹¹Tel Aviv Medical Center, Tel Aviv, ISR
¹²Department of Hematology, Tel Aviv medical center, Tel Aviv, Israel
¹³BMT Unit, Tel Aviv (Sourasky) Medical Center, Tel Aviv, Israel
¹⁴Bone Marrow Transplant Unit, Tel Aviv (Sourasky) Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

Wenbin Qian¹, Hui Liu, MD, PhD^2*, Wen Lei^2,3*, Linqin Wang^4* and Panpan Chen^5*

¹Department of Hematology,The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
²Department of Hematology, The Second Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China
³The Second Affiliated Hospital, College of Medicine, Zhejiang University, Department of Hematology, China, Hangzhou, China
⁴Bone Marrow Transplantation Center of The First Affiliated Hospital & Liangzhu Laboratory, Zhejiang University School of Medicine, Hangzhou, China
⁵Department of Hematology,The Second Affiliated Hospital, College of Medicine, Zhejiang University,Hangzhou, China, Hangzhou, China

Fabian Mueller, MD¹, Krish Patel, MD^2*, Ran Reshef, MD, MSc³, Mohamad Cherry, MD, MSc⁴, Richard Nash, MD^5*, Ernesto Ayala, MD⁶, Jingmei Hsu, MD, PhD⁷, Jacques Azzi^8*, Peter Vandenberghe, MD, PhD⁹, Roch Houot, MD, PhD^10*, Bastian von Tresckow¹¹, Giuseppina Stifano^12*, Ashley Koegel, MD¹³, Susana Falcon^13*, Burhan Chaudhry^13*, Lisa Kelly^13*, Jerill Thorpe^14*, Alyse Frisbee^14*, Sam Charab^14*, Sharmila Das^13*, Thomas Ly^15*, Ken Ogasawara, PhD, MPH^13* and Paolo Caimi^16*

¹Department of Internal Medicine 5, Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany
²Center for Blood Disorders and Cellular Therapy, Swedish Cancer Institute, Seattle, WA
³Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY
⁴Atlantic Health System, Morristown, NJ
⁵Health One Cares, Denver, CO
⁶Department of Hematology/Oncology, Mayo Clinic, Jacksonville, FL
⁷NYU Perlmutter Cancer Center, NYU Grossman School of Medicine, New York, NY
⁸Icahn School of Medicine at Mount Sinai, New York, NY
⁹University Hospitals Leuven, Leuven, Belgium
¹⁰University Hospital CHU de Rennes, Rennes, France
¹¹Department of Hematology and Stem Cell Transplantation, West German Cancer Center and German Cancer consortium (DKTK partner site Essen), University Hospital Essen, University of Duisburg-Essen, Essen, Germany
¹²Bristol Myers Squibb, Cambridge, MA
¹³Bristol Myers Squibb, Princeton, NJ
¹⁴Bristol Myers Squibb, Seattle, WA
¹⁵Bristol Myers Squibb, San Diego, CA
¹⁶Cleveland Clinic Taussig Cancer Institute, Cleveland, OH

Thomas Pfeiffer^1*, Stephanie Hyde^1*, Amanda F. Cashen, MD², Jeffrey J. Bednarski, MD, PhD¹ and Todd A Fehniger³

¹Department of Pediatrics, Division of Hematology / Oncology, Washington University School of Medicine, Saint Louis, MO
²Washington University School of Medicine, Saint Louis, MO
³Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO